DrugPatentWatch Database Preview
Taro Company Profile
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and thirteen approved drugs.
There are ten US patents protecting TARO drugs. There are three tentative approvals on TARO drugs.
Summary for Taro
| US Patents: | 10 |
| Tradenames: | 111 |
| Ingredients: | 94 |
| NDAs: | 213 |
| Patent Litigation for Taro: | See patent lawsuits for Taro |
| PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | NITROFURAZONE | nitrofurazone | OINTMENT;TOPICAL | 086156-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharm Inds Ltd | OVIDE | malathion | LOTION;TOPICAL | 018613-001 | Aug 2, 1982 | AT | RX | Yes | Yes | 7,977,324 | ➤ Sign Up | Y | ➤ Sign Up | ||
| Taro | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | LOTION;TOPICAL | 074272-001 | Sep 30, 1994 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SUPPOSITORY;RECTAL | 040603-002 | Oct 26, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro | HYDROCORTISONE | hydrocortisone | OINTMENT;TOPICAL | 040310-001 | Dec 29, 2000 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ➤ Sign Up |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,656,482 | ➤ Sign Up |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 5,881,926 | ➤ Sign Up |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Sign Up |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,656,482 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
Premature patent expirations for TARO
Non-Orange Book US Patents for Taro
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 5,886,038 | Composition and method for treatment of psoriasis | ➤ Sign Up |
| 8,039,657 | Process for preparing malathion for pharmaceutical use | ➤ Sign Up |
| 8,206,727 | Oral suspension of prednisolone acetate | ➤ Sign Up |
| 8,461,139 | Oral suspension of prednisolone acetate | ➤ Sign Up |
| 6,355,258 | Method for formulating spill resistant pharmaceutical compositions in semi-solid form | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Taro Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2003510259 | ➤ Sign Up |
| Japan | 2009503097 | ➤ Sign Up |
| Spain | 2276697 | ➤ Sign Up |
| European Patent Office | 2008649 | ➤ Sign Up |
| European Patent Office | 1244401 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2015 00014 | Denmark | ➤ Sign Up | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
| 1304992/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
| 80045 | Netherlands | ➤ Sign Up | PRODUCT NAME: FOSPHENYTOINUM-DI-NATRICUM; NATL REGISTRATION NO/DATE: RVG 22758 19980702; FIRST REGISTRATION: GB PL 00019/0157 19980204 |
| 60031 | Netherlands | ➤ Sign Up | PRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621 |
| 666 | Luxembourg | ➤ Sign Up | PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
